Genzyme Sues Lupin Over Generic Renvela Powder
Genzyme Corp. has sued India-based Lupin Ltd. and its U.S. affiliate in an effort to block a generic version of kidney disease treatment Renvela in powder form, following up on earlier...To view the full article, register now.
Already a subscriber? Click here to view full article